Related Experiment Video
Updated: Apr 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Use of a multistate model in survival predictions in cardiology studies
Natalia Montoya1,2, Alicia Quirós2, José M de la Torre-Hernández1
1Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, España Servicio de Cardiología Hospital Universitario Marqués de Valdecilla Instituto de Investigación Sanitaria Valdecilla (IDIVAL) Santander España.
Insights
Multistate models enhance survival analysis in cardiology by predicting disease progression. These models offer detailed insights into patient outcomes, improving prognostic accuracy for antithrombotic therapies.
Area of Science:
- Cardiovascular Medicine
- Biostatistics
- Medical Informatics
Background:
- Multistate models are valuable for survival analyses.
- Disease progression modeling is crucial in interventional cardiology.
Purpose of the Study:
- To model disease progression in interventional cardiology using a multistate model.
- To assess the efficacy and prognosis of antithrombotic therapies in elderly patients with atrial fibrillation.
Main Methods:
- Fitted a multistate model to the PACO-PCI database (1057 patients).
- Defined 4 states: treatment, myocardial infarction/revascularization, bleeding, and death.
- Compared with multivariate Cox models.
Main Results:
- Identified common survival factors: PreciseDAPT, HAS-BLED, anemia, diabetes, chronic kidney disease, vessels treated, and left ventricular function.
- Multistate models revealed specific transition influences (e.g., hemorrhage impact on myocardial infarction/revascularization).
- Multistate models provide transition-specific predictor insights, unlike Cox models.
Conclusions:
- Multistate models offer advantages in survival analysis.
- These models enable individualized patient predictions based on clinical characteristics and disease progression.
Introduction And Objectives:
Multistate models have proven to be effective tools in survival analyses. We propose modeling disease progression in interventional cardiology studies using a multistate model.
Methods:
The model was fitted to the PACO-PCI database including a total of 1057 elderly patients with atrial fibrillation revascularized with drug-eluting stents to assess the efficacy profile and prognosis of different antithrombotic therapies. The model defines a total of 4 states: treatment, myocardial infarction and/or revascularization, bleeding, and death, with significant factors for each transition, and was compared using a multivariate Cox model.
Results:
Survival factors common to both analyses were the PreciseDAPT and HAS-BLED scales, anemia, diabetes mellitus, chronic kidney disease, number of vessels treated, and left ventricular function. The multistate model also shows that after a new hemorrhage the probability of myocardial infarction and/or revascularization is influenced by the treatment of left main coronary artery disease and the transition to death from previous coronary artery bypass graft. Compared with Cox models, multistate models allow us to tell which transition in the model is influenced by each predictor.
Conclusions:
The results illustrate the additional advantages of multistate models in survival analyses through individual predictions for the patients based on their clinical characteristics and disease progression.
Related Concept Videos
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Cardiomyopathy V: Interprofessional Care
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Cardiomyopathy III: Hypertrophic Cardiomyopathy

